abstract |
The present invention relates to a composition for inhibiting cancer stem cell growth and its use, wherein the EMP3 inhibitor is treated to reduce the self-renewal ability, invasion ability, and migration ability of cancer stem cells expressing ALDH1, thereby inhibiting the growth of cancer stem cells. And, thereby, it is possible to effectively treat cancer with cancer stem cell characteristics that are resistant to existing anti-cancer treatment methods. |